All News

Published in Pregnancy, a single-center 20-year study of gastroschisis deliveries found that ultrasound-based bowel concern as a sole indication for delivery did not improve neonatal outcomes.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

Using deep plasma proteomics rather than circulating tumor DNA, Certitude Breast addresses a known early-detection gap for breast cancer, particularly in women with dense breast tissue.

Susan Loeb-Zeitlin, MD, FACOG, breaks down the recently-updated ACOG guidance related to postmenopausal bleeding.

Aiming to address high maternal mortality rates and close the drug development gap for the 90% of pregnant patients using medications, SMFM's ongoing campaign highlights the vital role of perinatologists in managing high-risk pregnancies.

A cross-sectional analysis of 2024 national survey data published in JAMA Women's Health estimates that 17.9 million US women aged 45 to 64 are overdue for at least 1 recommended cancer screening.

Melissa Loseke, DO, highlighted evidence that testosterone therapy in women may improve energy, mood, cognition, and cardiometabolic markers beyond sexual function.

An updated consensus statement from the Society for Maternal-Fetal Medicine confirms that acetaminophen remains the safest first-line treatment for pain and fever during pregnancy.

The FDA has approved Wockhardt’s cefepime and zidebactam, a novel intravenous antibiotic that targets multiple penicillin-binding proteins to treat adults with complicated urinary tract infections.

These are the top 5 headlines you might have missed from May 2026.

For patients who express hesitancy about receiving multiple vaccines at once, Sonneveld pointed to the layered reassurance the evidence base now provides.

Esther H. Chung, MD, discusses how earlier fertility education, emotional screening, and structured referrals can improve patient experiences and outcomes in infertility care.

The Policy Center for Maternal Mental Health's 2026 report cards show a slight national grade improvement to a "C," though a new parental support domain returned an "F" across the United States.

A novel methylation signature may help identify patients unlikely to respond to progestin therapy, according to Hugh Taylor, MD.

Genevieve Neal-Perry, MD, PhD, highlights that phase 4 real-world data confirm that fezolinetant significantly reduces VMS bother, particularly in high-burden groups such as Black women and patients with obesity.

Progressive menstrual pain should prompt earlier evaluation for endometriosis to prevent missed opportunities and delayed care, Hugh Taylor, MD, explained.

David Shalowitz explains why experts now recommend a dual approach for most patients with postmenopausal bleeding due to limitations in ultrasound accuracy.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

States with abortion restrictions saw increased expectant management and reliance on less effective treatment regimens for spontaneous abortion.

Expanding access and clinician education may enhance effectiveness of HPV self-collection programs.

Earlier initiation of conservative therapies may improve outcomes and reduce the need for advanced treatment in stress urinary incontinence.

Cervical cancer screening increased by 2.2 percentage points after program implementation, though 12.6% of eligible individuals received testing kits.

At ACOG, David Shalowitz, MD, highlighted the biggest takeaways from April's updated guidance on postmenopausal bleeding.

Early postpartum visits were associated with a 44% reduction in acute care use among patients with SUD, regardless of care model.

An at-home menstrual blood diagnostic platform in development may enable earlier, noninvasive detection of endometriosis.

A secondary analysis found that reduced time in target glucose range during labor was associated with increased adverse neonatal outcomes in gestational diabetes.

Sameena Rahman, MD, FACOG, asserts that the word "metabolic" in PMOS should fundamentally change clinical perceptions, transforming it from a GYN issue into a universally treated systemic condition.

After adjusting for the mother's mental health, a new meta-analysis found no significant association between common antidepressant use in pregnancy and autism or ADHD in chidlren.